Ultraviolet spectrophotometry is widely used for the analysis of theophylline in blood, for purposes of moni- Pharmacol. Exp. Ther. 97, 283 (1949)] presented in this paper eliminates barbiturate interference. After solvent extraction and back extraction into NaOH, the pH of the alkaline solution is adjusted from pH 13 to 10 before spectrophotometric measurement. This shifts the barbiturate absorption maximum from 255 to 240 nm, perm'rtting accurate analysis of theophylline, the spectrum of which is unaffected by the pH change.
barbital, a component of common oral theophylline preparations, interferes with assays now in use. The modification of the method of Schack and Waxier [J. Pharmacol. Exp. Ther. 97, 283 (1949) ] presented in this paper eliminates barbiturate interference. After solvent extraction and back extraction into NaOH, the pH of the alkaline solution is adjusted from pH 13 to 10 before spectrophotometric measurement. This shifts the barbiturate absorption maximum from 255 to 240 nm, perm'rtting accurate analysis of theophylline, the spectrum of which is unaffected by the pH change. (1) (2) (3) (4) (5) , the spectrophotometric method of Schack and Waxler (6), or modifications of it, has been used. In all instances, spectrophotometry was at a final pH of 13. Under this condition, barbiturates, including phenobarbital (a component of widely used oral theophylline preparations), interfere with the assay. In our modification, the pH is adjusted to pH 10 before the spec-
The resulting hypsochromic shift in the phenobarbital spectrum is sufficient to permit resolution of the theophylline absorption peak, which is essentially unaffected by this pH adjustment. The described procedure is suitable for emergency as well as routine use. Add 1 ml of stock standard to 100 ml of drug-free plasma or serum. Divide it into 4-ml aliquota and store at 15 #{176}C. The working standard is stable for at least six months.
Materials and Methods

Apparatus
Procedure
Place 3 ml of sample (or plasma standard), 2 ml of buffer, and 30 ml of chloroform/isopropanol mixture into a 60-ml separatory funnel. Extract gently for about 5 mm and filter the chloroform through Whatman No. 1 filter paper. Add 3 ml of NaOH to 25 ml of the filtered chloroform and shake gently for 5 mm; use 50-ml round-bottomed centrifuge tubes with ground-glass stoppers. After centrifugation, remove 2.0 ml of the aqueous phase, add 0.1 ml of NH4C1, mix, and determine the ultraviolet absorption spectrum. Use a solution containing NaOH and NH4C1 in the same ratio as the reference solution. If theophylline is present, there will be an absorption peak at 275 nm. Subtract the absorbance (1 cm, 1 g/dl) at 300 nm from that at 280 nm and determine the concentration by comparison with an identically processed plasma standard. Subtracting the absorbance at 300 nm eliminates some baseline errors resulting from traces of endogenous color or turbidity.
Results and Discussion
A standard curve was prepared by extracting plasma samples containing various concentrations of added theophylline and analyzing them as described. Drug concentration and absorbance (A280 -A300) were linearly related over a range of 2 to 20 mg/liter. The sensitivity (curve b, Ultraviolet spectrophotometry cannot, of course, resolve a mixture of compounds with overlapping spectra. Any weakly acidic ultraviolet-absorbing drug that reaches a sufficiently high concentration in the blood theoretically will interfere. Phenylbutazone and sulfonamides are commonly used drugs that could interfere, but are not likely to be coadministered with theophylline. Contrary to common belief, caffeine is not extracted from the solvent by the dilute NaOH; 50 g of caffeine added to chlorQform/isopropanol was not extracted by NaOH (0.1 mol/liter).
Because its pKa is greater than 14, caffeine has negligible acidic properties. An hour after a subject ingested two strong cups of cocoa, a plasma "theobromine" concentration corresponding to 1,5 mg of theophylline per liter was obtained. Theobromine-containing medications will interfere, but rarely are used.
Phenobarbital interference cannot be passed over as lightly as the drugs just mentioned, because it is included Decreasing the pH from 13 to 10 by adding NH4C1 shifts the phenobarbital peak from 255 to 240 nm, away from the theophylline maximum. At 280 nm the interference from phenobarbital is negligible. Figure  2 shows these relationships.
A specimen from a patient receiving phenobarbital and theophylline yielded the spectrum shown in Figure 3 .
The differential spectrophotometric method of Gupta and Lundberg (7) can be used if barbiturates are present, but requires 5 ml of blood, is probably insufficiently sensitive for therapeutic monitoring, and, as the authors indicate, was intended for use in diagnosis of drug overdose.
Schack and Waxier (6) suggested that if the particular barbiturate was known, a correction might possibly be made by using a two-wavelength measurement, simultaneous equations, and the molar absorption value, but no data were given to support this suggestion. No foreknowledge of the use of barbiturates is required in the procedure described here.
A potential drawback to spectrophotometric procedures is that they are subject to interferences from metabolites that have absorption spectra similar to that of the parent than the described procedure, may resolve theophylline from other drugs, and may therefore be preferable for pharmacokinetic studies, but a spectrophotometric procedure is suitable for round-the-clock management of acute asthmatic emergencies, as well as chronic care. The procedure described eliminates the most important and common source of interference, can be completed in 20-30 mm, and is technically suited for emergency and routine use. 
